Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Safaeian, Mahboobeh ^a   Hildesheim, Allan ^a   Gonzalez, Paula ^b   Yu, Kai ^a   Porras, Carolina ^b   Li, Qizhai ^c   Rodriguez, Ana Cecilia ^b   Sherman, Mark E ^a   Schiffman, Mark ^a   Wacholder, Sholom ^a   Burk, Robert ^d   Herrero, Rolando ^b   Burdette, Laurie ^e   Chanock, Stephen J ^e   Wang, Sophia S ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^c CHINESE ACADEMY OF SCIENCES   (China)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e SAIC FREDERICK INC   (United States)

^f Division of Etiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; C1RL GENE; CANCER RISK; CONTROLLED STUDY; COSTA RICA; DISEASE COURSE; FEMALE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HUMAN; IL2RA GENE; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRDX3 GENE; RPS19 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TELO2 GENE; TUMOR GENE; TYMS GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; CANCER STAGING; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; GENETICS; LONGITUDINAL STUDY; PAPILLOMA VIRUS; PATHOGENICITY; PRECANCER; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

PEROXIREDOXIN 3; PRDX3 PROTEIN, HUMAN; RIBOSOMAL PROTEIN S19; RIBOSOME PROTEIN;

CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; COSTA RICA; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PEROXIREDOXIN III; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS; RIBOSOMAL PROTEINS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84859509236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033619     Document Type: Article

References (21)

1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907.
2. Czene K, Lichtenstein P, Hemminki K, (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 99: 260-266.
3. Hemminki K, Chen B, (2006) Familial risks for cervical tumors in full and half siblings: etiologic apportioning. Cancer Epidemiol Biomarkers Prev 15: 1413-1414.
4. Hemminki K, Dong C, Vaittinen P, (1999) Familial risks in cervical cancer: is there a hereditary component? Int J Cancer 82: 775-781.
5. Hussain SK, Sundquist J, Hemminki K, (2008) Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer Database. Int J Cancer 122: 1873-1878.
6. Hildesheim A, Wang SS, (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89: 229-240.
7. Carrington M, Wang S, Martin MP, Gao X, Schiffman M, et al. (2005) Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 201: 1069-1075.
8. Wang SS, Gonzalez P, Yu K, Porras C, Li Q, et al. (2010) Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer. PLoS One 5: e8667.
9. Gazda HT, Sieff CA, (2006) Recent insights into the pathogenesis of Diamond-Blackfan anaemia. Br J Haematol 135: 149-157 BJH6268 [pii];10.1111/j.1365-2141.2006.06268.x [doi].
10. Peskin AV, Cox AG, Nagy P, Morgan PE, Hampton MB, et al. (2010) Removal of amino acid, peptide and protein hydroperoxides by reaction with peroxiredoxins 2 and 3. Biochem J 432: 313-321 BJ20101156 [pii];10.1042/BJ20101156 [doi].
11. Kim K, Yu M, Han S, Oh I, Choi YJ, et al. (2009) Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. Oncol Rep 21: 1391-1396.
12. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, et al. (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464-474.
13. Herrero R, Schiffman MH, Bratti C, Hildesheim A, Balmaceda I, et al. (1997) Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1: 362-375.
14. Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, et al. (2002) Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 186: 598-605.
15. Wang SS, Bratti MC, Rodriguez AC, Herrero R, Burk RD, et al. (2009) Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis 199: 20-30.
16. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, et al. (2000) HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283: 87-93.
17. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, et al. (2005) Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191: 1796-1807.
18. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, et al. (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucl Acids Res 34: D617-D621.
19. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
20. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, et al. (2009) Pathway analysis by adaptive combination of P-values. Genet Epidemiol.
21. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 57: 289-300.